The study suggests that PLCγ1 is involved in FGFR1 signaling to favor tumorigenic progression in precancerous neuroendocrine cells and is required for SCLC development in vivo, independently of ERK1/2, AKT1, or STAT1. The gene discussed is FGFR1; the disease is small cell lung carcinoma.